A Real-World Pharmacovigilance study of FAERS Database for Fluvoxamine: Perspectives from Physicians and Pharmacists
This study provides a real-world pharmacovigilance analysis of fluvoxamine. It identifies several rare ADEs and clinically significant symptoms, particularly neuroleptic malignant syndrome and serotonin syndrome. Our study offers important insights for the clinical safety assessment of fluvoxamine.
Authors
- Fei Wang (ORCID: https://orcid.org/0000-0002-2757-5846)
- Haifeng Wang
- Na Li (ORCID: https://orcid.org/0000-0001-9739-8964)
- Jun Gu (ORCID: https://orcid.org/0000-0002-1508-6703)
- Liang Liu (ORCID: https://orcid.org/0000-0003-1743-8503)
- Jianhong Wu
- Weiming Xie
Institutions
- Jiangnan University (CN)
- Nantong University (CN)
- Wuxi Fourth People's Hospital (CN)
- The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN)
Publication Details
- Journal
- Brazilian Journal of Psychiatry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.47626/1516-4446-2025-4146
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Xiamen University